Excelsior Sciences
A bioanalytical scientist with expertise in LC/MS for small molecule ADME analysis is needed to profile new leads and advance novel small molecule therapeutics across multiple modalities and disease areas.
Company Size
1-10 employees
Excelsior Sciences leverages blocc chemistry — automated, AI-friendly small molecule synthesis — to accelerate drug discovery and scale from molecule to manufacturing. Their platform uses machine-ready chemical building blocks and closed-loop AI-guided synthesis to transform small-molecule innovation into a modular, iterative process accessible to automation and non-specialists. The company operates at the intersection of chemistry and AI, targeting pharmaceuticals and broader materials applications.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Excelsior Sciences.
17% below the average for this role
Scientist I
LanceSoft
Principal Scientist - Bioresearch Laboratory
Massachusetts General Hospital
Assistant Scientist I/II Preclinical Development
LanceSoft
Scientist
Artech
Scientist / Senior Scientist, Bioanalytical LC–MS – Oligonucleotide
Alloy Therapeutics
Associate Scientist to Scientist, DMPK
Structure Therapeutics